Article info

Download PDFPDF
Concise report
Antibodies to infliximab in Remicade-treated rheumatic patients show identical reactivity towards biosimilars

Authors

  1. Correspondence to Dr Daniel Nagore, Progenika-Grifols, 504 Parque Tecnológico Bizkaia, Derio 48160 Spain; daniel.nagore{at}progenika.grifols.com
View Full Text

Citation

Ruiz-Argüello MB, Maguregui A, Ruiz del Agua A, et al
Antibodies to infliximab in Remicade-treated rheumatic patients show identical reactivity towards biosimilars

Publication history

  • Received September 29, 2015
  • Revised February 16, 2016
  • Accepted February 21, 2016
  • First published March 10, 2016.
Online issue publication 
August 10, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.